We are live on ! Find out more
32.91 USD
-0.70
2.08%
At close Updated Aug 28, 3:07 PM EDT
1 day
-2.08%
5 days
-1.23%
1 month
13.76%
3 months
46.33%
6 months
27.36%
Year to date
-1.44%
1 year
9.99%
5 years
-61.35%
10 years
158.93%
 

About: Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

Employees: 2,900

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 15.4%
Neutral 76.9%
Negative 7.7%
Neutral
PRNewsWire
22 hours ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
Neutral
GlobeNewsWire
2 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
Neutral
PRNewsWire
4 days ago
AZENTA ANNOUNCES LEADERSHIP TRANSITION
Current Director Dr. Martin Madaus Appointed Interim CEO Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance BURLINGTON, Mass., Aug. 24, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus has been appointed interim President and CEO, and that John Marotta has resigned as an executive officer and director of the Company.
AZENTA ANNOUNCES LEADERSHIP TRANSITION
Negative
Seeking Alpha
14 days ago
Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue
AZTA went down for a long time, resulting in a multi-year low in May 2026, but the stock has rallied higher since then. While the stock has doubled in value, there is a chart that suggests to be wary of the rally because it could unwind itself in the near future. The current financial model from AZTA makes a case for being long, but that depends on whether AZTA can hit the targets laid out.
Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue
Neutral
Seeking Alpha
23 days ago
Azenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript
Azenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript
Azenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript
Positive
MarketBeat
23 days ago
Azenta Q3 Earnings Call Highlights
Azenta NASDAQ: AZTA reported third-quarter fiscal 2026 revenue that exceeded its outlook, as growth in recurring-revenue businesses and improved Multiomics performance helped offset continued unevenness in capital equipment markets.
Azenta Q3 Earnings Call Highlights
Neutral
PRNewsWire
23 days ago
Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.
BURLINGTON, Mass., Aug. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2026.
Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.
Positive
Seeking Alpha
1 month ago
Conestoga Small Cap Composite Q2 2026 Portfolio Activity
DGII stock moved higher after the company reported record revenue and continued progress shifting toward a more recurring revenue-oriented business model. We remain encouraged by DSGX's mission-critical software, highly recurring revenue model, and disciplined capital allocation strategy, which continue to support our long-term investment thesis. We believe Kodiak Gas Services is well positioned to benefit from growing demand for natural gas infrastructure, LNG exports, and power generation supporting AI-related data center development.
Conestoga Small Cap Composite Q2 2026 Portfolio Activity
Neutral
PRNewsWire
1 month ago
Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast
BURLINGTON, Mass., July 22, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2026 earnings which ended on June 30, 2026, on Tuesday, August 4, 2026, after the market closes.
Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast
Neutral
PRNewsWire
1 month ago
Azenta Completes Sale of B Medical Systems
BURLINGTON, Mass., July 8, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the completion of the previously disclosed sale of its B Medical Systems business to Thelema S.
Azenta Completes Sale of B Medical Systems
Price charts implemented using Lightweight Charts™